Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1996;22(6):588–590. doi: 10.1007/BF01708102

Surfactant replacement therapy in acute respiratory distress syndrome from viral pneumonia

G Putz 1,, C Hörmann 1, W Koller 1, G Schön 2
PMCID: PMC7095348  PMID: 8814477

Abstract

A modified natural surfactant was administered to a patient with life-threatening adult respiratory distress sydrome caused by viral pneumonia. Subsequently, there was a marked improvement in gas exchange. In order to assess the mechanism for improved oxygenation, computed tomography of the lungs was done. Quantitative analysis of the scans taken before and after surfactant administration indicates that improvement in gas exchange was largely due to the expansion of underinflated and collapsed lung areas. Although this is a single case report, it provides insight into the possible beneficial effect of instilled surfactant in severe respiratory distress from viral pneumonia.

Key words: ARDS, Pneumonia, Pulmonary surfactants, Surfactant replacement therapy

References

  • 1.Spragg RG, Gilliard N, Richman P, Smith RM, Hite RD, Pappert D, Robertson B, Curstedt T, Strayer D. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest. 1994;105:195–202. doi: 10.1378/chest.105.1.195. [DOI] [PubMed] [Google Scholar]
  • 2.Weg JG, Balk RA, Tharratt RS, Jenkinson SG, Shah JB, Zaccardelli D, Horton J, Pattishall EN. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. JAMA. 1994;272:1433–1438. [PubMed] [Google Scholar]
  • 3.Baum M, Benzer H, Putensen Ch, Koller W, Putz G. Biphasic positive airway pressure (BIPAP): a new form of assisted ventilation. Anaesthesist. 1989;38:452–458. [PubMed] [Google Scholar]
  • 4.Lachmann B, Gommers D. Is it rational to treat pneumonia with exogenous surfactant? Eur Respir J. 1993;6:1427–1428. [PubMed] [Google Scholar]
  • 5.Goldsmith LS, Greenspan JS, Rubenstein SD, Wolfson MR, Shaffer TH. Immediate improvement in lung volume after exogenous surfactant: alveolar recruitment versus increased distention. J Pediatr. 1991;119:424–428. doi: 10.1016/s0022-3476(05)82057-8. [DOI] [PubMed] [Google Scholar]
  • 6.Gattinoni L, Pesenti A, Bombino M, Baglioni S, Rivolta M, Rossi F, Rossi G, Fumagalli R, Marcolin R, Mascheroni D, Torresin A. Relationships between lung computed tomographic density, gas exchange, and PEEP in acute respiratory failure. Anesthesiology. 1988;69:824–832. doi: 10.1097/00000542-198812000-00005. [DOI] [PubMed] [Google Scholar]
  • 7.Gommers D, Vilstrup C, Bos JAH, Larsson A, Werner O, Hannappel E, Lachmann B. Exogenous surfactant therapy increases static lung compliance, and cannot be assessed by measurements of dynamic compliance alone. Crit Care Med. 1993;21:567–574. doi: 10.1097/00003246-199304000-00019. [DOI] [PubMed] [Google Scholar]
  • 8.Gattinoni L, Bombino M, Pelosi P, Lissoni A, Pesenti A, Fumagalli R, Tagliabue M. Lung structure and function in different stages of severe adult respiratory distress syndrome. JAMA. 1994;271:1772–1779. [PubMed] [Google Scholar]
  • 9.Gattinoni L, Pelosi P, Vitale G, Pesenti A, D'Andrea L, Mascheroni D. Body position changes redistribute, lung computed-tomography density in patients with acute respiratory failure. Anesthesiology. 1991;74:15–23. doi: 10.1097/00000542-199101000-00004. [DOI] [PubMed] [Google Scholar]

Articles from Intensive Care Medicine are provided here courtesy of Nature Publishing Group

RESOURCES